BioAtla Company
BioAtla develops safer, more effective drugs for cancer using a proprietary next-generation antibody discovery and evolution platform.
Founded Date:
2007
Estimated Revenue:
$10M to $50M
Employee Number:
51-100
Industry:
PharmTech
Technology:
Cancer
Headquarters:
San Diego, California, United States
Funding Status:
IPO